Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kelsell, R. E.
Right arrow Articles by Hunt, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelsell, R. E.
Right arrow Articles by Hunt, D. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics Pages 597-601


Localisation of a gene for dominant cone-rod dystrophy (CORD6) to chromosome 17p
Introduction
Results
Discussion
Materials And Methods
Acknowledgements
Abbreviations
References


Localisation of a gene for dominant cone-rod dystrophy (CORD6) to chromosome 17p

Localisation of a gene for dominant cone-rod dystrophy ( CORD6 ) to chromosome 17p Rosemary E. Kelsell, Kevin Evans, Cheryl Y. Gregory, Anthony T. Moore1, Alan C. Bird and David M. Hunt*

Department of Molecular Genetics, Institute of Ophthalmology, University College London, Bath Street,London EC1V 9EL,UK and1Department of Ophthalmology, Addenbrooke's Hospital, Hills Road,Cambridge CB2 2QQ,UK

Received December 3, 1996;Revised and Accepted January 21, 1997

We have performed genetic linkage analysis on a four generation British family with cone-rod dystrophy. Significant linkage to the disease gene was obtained with eight marker loci situated on chromosome 17p12-p13. A maximum two-point lod score of 5.93 with no recombination was obtained with marker locusD17S1844. Critical recombinants identified with flanking marker loci placed the disease gene betweenD17S796/D17S938andD17S954, an interval estimated to be 8 cM in size. This new localisation for autosomal dominant cone-rod dystrophy (CORD6) overlaps with regions attributed previously to Leber's congenital amaurosis, central areolar choroidal dystrophy and dominant cone dystrophy. Given their differences in phenotype, the most plausible explanation would be that these different retinal disorders are caused by mutations in different genes mapping close together within the genome.

INTRODUCTION

The chorioretinal dystrophies constitute the largest subgroup of inherited eye disorders which lead to blindness. Cone-rod dystrophy is a severe example of this subgroup, being characterised by the initial loss of visual acuity and colour vision (associated with the degeneration of cone photoreceptor cells), followed by night blindness and peripheral visual field loss (associated with the degeneration of rod photoreceptor cells) (1 ).

Autosomal dominant, X-linked and recessive modes of inheritance have been described and recent genetic studies have implicated nine different genomic loci in the aetiology of cone-rod dystrophy. Autosomal dominant forms of the disorder have been associated with mutations in the peripherin/RDS gene on chromosome 6p21.2-cen (2 ,3 ) and linkage to chromosome 19q13.3-q13.4 has also been reported (4 ,5 ). An X-linked form of the disease has been linked to Xp21.1-p11.3 (6 ). Autosomal recessive forms of cone-rod dystrophy in association with Bardet-Beidl syndrome have been linked, by homozygosity mapping to chromosomes 3, 11q13, 15 and 16q21 (7 -10 ). In addition, two sporadic cases of cone-rod dystrophy have been reported; one in association with a cytogenetically visible deletion of chromosome 18q211-213 (11 ) and the other in association with neurofibromatosis, suggestive of a cone-rod dystrophy gene situated close to theNF1 gene on chromosome 17q11.2 (12 ). Thus, there appear to be a number of genes situated throughout the genome which are involved in the development of the various forms of cone-rod dystrophy.

We undertook a molecular genetic study of a British family with autosomal dominant cone-rod dystrophy. The ophthalmological examination of affected individuals is described in detail elsewhere (K. Evanset al., in preparation). Briefly, the disease in this family displays an early onset, with loss of central vision reported before 7 years of age, progressing to the peripheral visual field later in life. In this report, we present genetic linkage data on this four generation pedigree which establishes a new localisation for cone-rod dystrophy (CORD6) to chromosome 17p12-p13.

RESULTS

A total genome search was undertaken, focusing on previously assigned loci. The two genomic regions already implicated in autosomal dominant cone-rod dystrophy, chromosome 6p21.2-cen containing the peripherin/RDS gene, and chromosome 19q13.3-q13.4, were chosen as the first candidate areas for linkage analysis. These two regions were excluded in our cone-rod dystrophy family (data not shown). Other regions of the genome previously assigned to retinal dystrophy loci were then investigated. It was with marker loci mapping to chromosome 17p that we obtained evidence for linkage in our autosomal dominant cone-rod dystrophy family.

Genotyping was performed with 14 microsatellite marker loci situated on chromosome 17p and the two-point lod scores are presented in Figure1 . Significant linkage was obtained with eight of these marker loci and a maximum lod score of 5.93 ([theta] = 0.00)was obtained withD17S1844.The haplotypes that define the most likely chromosomal interval for the disease-causing gene are indicated in Figure2 . The unaffected individual III-7 and the affected individual III-9 are recombinant forD17S796/D17S938, placing the disease gene centromeric toD17S796/D17S938. The affected individual III-4 is recombinant forD17S954 (as well as the more centromeric marker lociD17S799 andD17S945), placing the cone-rod dystrophy gene telomeric toD17S954. Four of the marker loci that gave a maximum lod score at zero recombination were completely informative in all these recombinant individuals. Therefore, the cone-rod dystrophy gene in this family is flanked by marker lociD17S796/D17S938(two recombination events) andD17S954 (one recombination event), a region estimated to be 8 cM in size (13 ). According to the most recent genetic map of the region, the marker order centromeric fromD17S804 isD17S804-D17S945-D17S1879/D17S1852/D17S954-D17S799 (13 ). However, the recombination events in our family placeD17S945 in a more centromeric position:D17S804-D17S1879/D17S1852-D17S954-D17S799/D17S945. The genetic interval of 8 cM betweenD17S796/D17S938andD17S954 is, therefore, approximate.


Figure 1.CORD6 and other retinal disease genes mapping to chromosome 17p. The table to the right shows the two-point lod scores for linkage between autosomal dominant cone-rod dystrophy and marker loci on chromosome 17p. *Marker locusD17S945 is excluded from the cone-rod dystrophy locus giving a -2.00 lod score at [theta] = 0.04. The region to whichCORD6 maps is depicted schematically just to the left of this table. The approximate positions of the other retinal disease genes and their flanking marker loci are also shown to the left (not to scale: the precise position of the telomeric CACD flanking markerD17S5, compared with the Genethon markers situated in this region is not published). Cone dystrophy, central areolar choroidal dystrophy (CACD) and Leber's congenital amaurosis (LCA) overlap, or map within the region forCORD6. See text for references.


Figure 2. Autosomal dominant cone-rod dystrophy pedigree and haplotype results of 14 microsatellite marker loci situated on chromosome 17p. The identities of microsatellite markers are shown to the right of individual IV-1. The haplotype which appears to be segregating with disease in this family is boxed.

DISCUSSION

We have localised the gene responsible for autosomal dominant cone-rod dystrophy in this study (CORD6), to within an ~8 cM region betweenD17S796/D17S938 andD17S954 on chromosome 17p12-p13. Several other retinal diseases have also been mapped to this region of the genome (see Fig.1 ). Leber's congenital amaurosis, a recessive disease responsible for congenital blindness, maps to withinD17S938 andD17S1353, a 1 cM region situated entirely within the region forCORD6 (14 ,15 ). Central areolar choroidal dystrophy, a dominant progressive disease resulting in visual loss maps to withinD17S5 andD17S520, a 16 cM region which overlaps the 8 cM region assigned forCORD6 (16 ). Finally, two cases of dominant cone dystrophy have been mapped to chromosome 17p (17 ,18 ), the most refined localisation being betweenD17S926/D17S849 andD17S945 (17 ), a 25 cM region that includes the region of theCORD6 gene.

Leber's congenital amaurosis, central areolar choroidal dystrophy, and cone-rod dystrophy are different clinical entities. The progressive loss of the peripheral visual field exhibited in the affected individuals in this cone-rod dystrophy family also clearly distinguishes the phenotype from that of cone dystrophy (K. Evanset al., in preparation). Given their clinical differences, we believe that the most likely explanation is that these different degenerations are caused by mutations within different retinal genes mapping close together within the genome. Such a theory has been postulated before for chromosome 6q, a region associated with several other retinal abnormalities (19 ,20 ).

There are a number of candidate genes for the retinal disorders that map to chromosome 17p, for example, the gene for recoverin,RCV1 (21 ).D17S945 is a microsatellite marker which was isolated from a 50 kb cosmid clone containing the recoverin gene (22 ). In our family, two individuals (III-3 and III-4) were recombinant forD17S945, as well as more telomeric marker loci. Thus, as is indicated by the exclusion data forD17S945 in Figure1 , the recoverin gene is an unlikely candidate for cone-rod dystrophy. Indeed,RCV1 has been similarly ruled out as a candidate for Leber's congenital amaurosis and cone dystrophy mapping to 17p (14 ,17 ,18 ). Recently, mutations have been identified in the human retinal guanylate cyclase gene,GUCD2, in affected members of some Leber's congenital amaurosis families mapping to this region of the genome (23 ). Other candidate genes include [beta]-arrestin 2,ARRB2, the pigment epithelium-derived factor gene,PEDF, and the gene encoding the phosphatidylinositol transfer protein,PITPN (24 ,25 ,26 ). No mutations were detected in thePITPNcoding region in patients with central choroidal areolar dystrophy (16 ) but it remains a candidate gene for other retinal disease genes mapping to 17p, such as the cone-rod dystrophy in this study.

Further refinement of theCORD6 locus is in progress, as well as the screening of candidate genes. The cloning of this disease gene should provide an insight into rod, as well as cone function and aid in our understanding of the pathophysiology of cone-rod dystrophy.

MATERIALS AND METHODS

EDTA-blood samples were obtained from 11 affected members, 11 unaffected members and five spouses for linkage analysis. DNA was extracted from these samples with a Nucleon II extraction kit (Scotlab Bioscience). Genotyping was performed with microsatellite marker loci as described previously (20 ). Briefly, 100 ng DNA samples were PCR amplified and labelled by [[alpha]-32P]dCTP incorporation. These amplified products were then separated by denaturing polyacrylamide gel electrophoresis and visualised by autoradiography. Data were collected using LINKSYS 3.1 (27 ), and two-point linkage analysis was performed using the MLINK sub-program of the LINKAGE package 5.10 (28 ). Allele frequencies were calculated from the five spouses in this family as well as an additional seven normal individuals taken from three other families. The cone-rod dystrophy phenotype in this family was analysed as an autosomal dominant trait, with complete penetrance, infantile onset and a frequency of 0.001 for the affected allele.

ACKNOWLEDGEMENTS

We thank Dr Marcelle Jay for genealogy work and the Human Genome Mapping Resources Centre for the provision of oligonucleotide primers. This work was supported by the Wellcome Trust (Grant Number 041905) and the TFC Frost Trust.

ABBREVIATIONS

ARRB2, [beta]-arrestin gene;CORD6, cone-rod dystrophy gene 6;GUCD2, guanylate cyclase gene;NF1, neurofibromatosis 1 gene;PEDF, pigment epithelium-derived factor gene;PITPN, phosphatidylinositol transfer gene;RCV1, recoverin gene;RDS, retinal degeneration slow gene.

REFERENCES

1 Moore, A,T. (1992) Cone and cone-rod dystrophies. J. Med. Genet., 29, 289-290. MEDLINE Abstract

2 Nakazawa, M., Kikawa, E., Chida, Y. and Tamai, M. (1994) Asn244His mutation of the peripherin/RDS gene causing autosomal dominant cone-rod degeneration. Hum. Mol. Genet., 3, 1195-1196. MEDLINE Abstract

3 Nakazawa, M., Kikawa, E., Chida, Y., Wada, Y., Shiono, T. and Tamai, M. (1996) Autosomal dominant cone-rod dystrophy associated with mutations in codon 244 (Asn244His) and codon 184 (Tyr184Ser) of the peripherin/RDS gene. Arch. Ophthalmol., 114, 72-78. MEDLINE Abstract

4 Evans, K., Fryer, A., Inglehearn, C., Duvall-Young, J., Whittaker, J.L., Gregory, C.Y., Butler, R., Ebenezer, N., Hunt, D.M. and Bhattacharya, S. (1994) Genetic linkage of cone-rod retinal dystrophy to chromosome 19q and evidence for segregation distortion. Nature Genet., 6, 210-213. MEDLINE Abstract

5 Gregory, C.Y., Evans, K., Whittaker, J.L., Fryer, A., Weissenbach, J. and Bhattacharya, S.S. (1994) Refinement of the cone-rod retinal dystrophy locus on chromosome 19q. Am. J. Hum. Genet.,55, 1061-1063. MEDLINE Abstract

6 Hong, H-K, Ferrell, R.E. and Gorin, M.B. (1994) Clinical diversity and chromosomal localization of X-linked cone dystrophy (COD1). Am. J. Hum. Genet., 55, 1173-1181.

7 Sheffield, V.C., Carmi, R., Kwitek-Black, A., Rokhlina, T., Nishimura, D., Duyk, G.M., Elbedour, K., Sunden, S.L. and Stone, E.M. (1994) Identification of a Bardet-Biedl syndrome locus on chromosome 3 and evaluation of an efficient approach to homozygosity mapping. Hum. Mol. Genet., 3, 1331-1335. MEDLINE Abstract

8 Leppert, M., Baird, L., Anderson, K.L., Otterud, B., Lupske, J.R. and Lewis, R.A (1994) Bardet-Biedl syndrome is linked to markers on chromosome 11q and is genetically heterogeneous. Nature Genet., 7, 108-112. MEDLINE Abstract

9 Carmi, R., Rokhlina, T., Kwitek-Black, A.E., Elbedour, K., Nishimura, D., Stone, E.M. and Sheffield, V.C. (1995) Use of a DNA pooling strategy to identify a human obesity syndrome locus on chromosome-15. Hum. Mol. Genet., 4, 9-13. MEDLINE Abstract

10 Kwitek-Black, A.E., Carmi, R., Duyk, G.M., Buetow, K.H., Elbedour, K., Parvari, R., Yandava, C.N., Stone, E.M. and Sheffield, V.C. (1993) Linkage of Bardet-Biedl syndrome to chromosome 16q and evidence for non-allelic genetic heterogeneity. Nature Genet.,5, 392-396. MEDLINE Abstract

11 Warburg, M., Sjo, O., Tranebjaerg, L. and Fledelius, H.C. (1991) Deletion mapping of a retinal cone-rod dystrophy:assignment to 18q211. Am. J. Med. Genet.,39, 288-293. MEDLINE Abstract

12 Kylstra, J.A. and Aylsworth, A.S. (1993) Cone-rod retinal dystrophy in a patient with neurofibromatosis type 1. Can. J. Ophthalmol.,28, 79-80. MEDLINE Abstract

13 Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. (1996). A comprehensive genetic-map of the human genome based on 5264 microsatellites. Nature 380, 152-154. MEDLINE Abstract

14 Camuzat, A., Dollfus, H., Rozet, J-M., Gerber, S., Bonneau, D., Bonnemaison, M., Briard, M-L., Dufier, J-L., Ghazi, I., Loewski, C., Weissenbach, J., Frezal, J., Munnich, A. and Kaplan, J. (1995) A gene for Leber's congenital amaurosis maps to chromosome 17p. Hum. Mol. Genet., 4, 1447-1452. MEDLINE Abstract

15 Camuzat, A., Rozet, J-M., Dollfus, H., Gerber, S., Perrault, I., Weissenbach, J., Munnich, A. and Kaplan, J. (1996) Evidence of genetic heterogeneity of Leber's congenital amaurosis (LCA) and mapping of LCA1 to chromosome 17p13. Hum. Genet.,97, 798-801. MEDLINE Abstract

16 Lotery, A.J., Ennis, K.T., Silvestri, G., Nicholl, S., McGibbon, D., Collins, A.D. and Hughes, A. (1996) Localisation of a gene for central areolar choroidal dystrophy to chromosome 17p. Hum. Mol. Genet., 5, 705-708. MEDLINE Abstract

17 Balciuniene, J., Johansson, K., Sandgren, O., Wachtmeister, L., Holmgren, G. and Forsman, K. (1995) A gene for autosomal dominant progressive cone dystrophy (CORD5) maps to chromosome 17p12-p13. Genomics, 30, 281-286. MEDLINE Abstract

18 Small, K.W., Syrquin, M., Mullen, L. and Gehrs, K. (1996) Mapping of autosomal dominant cone degeneration to chromosome 17p. Am. J. Ophthalmol.,121, 13-18. MEDLINE Abstract

19 Small, K.W., Weber, J.L., Roses, A., Lennon, F., Vance, J.M. and Pericak-Vance, M.A. (1992) North Carolina macular dystrophy is assigned to chromosome 6. Genomics., 13, 681-685. MEDLINE Abstract

20 Kelsell, R.E., Godley, B.F., Evans, K., Tiffin, P.A.C., Gregory, C.Y., Plant, C., Moore, A.T., Bird, A.C. and Hunt, D.M. (1995) Localization of the gene for progressive bifocal chorioretinal atrophy (PBCRA) to chromosome 6q. Hum. Mol. Genet., 4, 1653-1656. MEDLINE Abstract

21 Weichmann, A.F., Akots, G., Hammarback, J.A., Pettenati, M.J., Rao, P.N. and Bowden, D.W. (1994) Genetic and physical mapping of human recoverin: a gene expressed in retinal photoreceptors. Invest. Ophthalmol. Vis. Sci.,35, 325-331.

22 Weichmann, A.F., Haro, K.C. and Bowden, D.W. (1994) Three microsatellite polymorphisms at the recoverin locus on chromosome 17. Hum. Mol. Genet., 3, 1028.

23 Perrault, I., Rozet, J.M., Calvas, P., Gerber, S., Camuzat, A., Dollfus, H., Chatelin, S., Souied, E., Ghazi, I., Loewski, C., Bonnemaison, M., Le Paslier, D., Frezal, J., Dufier, J-L., Pittler, S., Munnich, A. and Kaplan, J. (1996) Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis. Nature Genet., 14, 461-464. MEDLINE Abstract

24 Calabrese, G., Sallese, M., Stornaiuolo, A., Stuppia, L., Palka, G. and De Blas, A. (1994) Chromosome mapping of the human arrestin (SAG), [beta]-arrestin 2 (ARRB2), and [beta]-adrenergic receptor kinase 2 (ADRBK2) genes. Genomics, 23, 286-288. MEDLINE Abstract

25 Tombran-Tink, J., Pawar, H., Swaroop, A., Rodriguez, I. and Chader, G.J. (1994) Localization of the gene for pigment epithelium-derived factor (PEDF) to chromosome 17p13.1 and expression in cultured human retinoblastoma cells. Genomics, 19, 266-272. MEDLINE Abstract

26 Fitzgibbon, J., Pilz, A., Gayther, S., Appukuttan, B., Dulai, K.S., Delhanty, J.D.A., Helmkamp, Jr. G.M., Yarbrough, L.R. and Hunt, D.M. (1994) Localization of the gene encoding human phosphatidylinositol transfer protein (PITPN) to 17p13.3: a gene showing homology to the Drosophila retinal degeneration B gene (rdgB). Cytogenet. Cell Genet.,67, 205-207.

27 Attwood, J. and Bryant, S.A. (1988) A computer program to make analysis with LIPED and LINKAGE easier to perform and less prone to input errors. Am. J. Hum. Genet., 52, 259.

28 Lathrop, G.M., Lalouel, J.M., Julier, C. and Ott, J. (1984) Strategies for multipoint linkage analysis in humans. Proc. Natl. Acad. Sci.USA, 81, 3443-3446.


*To whom correspondence should be addressed


This page is maintained by OUP admin. Last updated Thu Mar 13 17:29:21 GMT 1997. Part of the OUP Journals World Wide Web service.Copyright Oxford University Press, 1996


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch OphthalmolHome page
K. W. Small, R. Silva-Garcia, N. Udar, E. V. Nguyen, and J. R. Heckenlively
New Mutation, P575L, in the GUCY2D Gene in a Family With Autosomal Dominant Progressive Cone Degeneration
Arch Ophthalmol, March 1, 2008; 126(3): 397 - 403.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Castori, E. M. Valente, M. Clementi, A. P. Tormene, F. Brancati, V. Caputo, and B. Dallapiccola
A Novel Locus for Autosomal Dominant Cone and Cone-Rod Dystrophies Maps to the 6p Gene Cluster of Retinal Dystrophies
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3539 - 3544.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Michaelides, S. Johnson, A. K. Tekriwal, G. E. Holder, C. Bellmann, E. Kinning, G. Woodruff, R. C. Trembath, D. M. Hunt, and A. T. Moore
An Early-Onset Autosomal Dominant Macular Dystrophy (MCDR3) Resembling North Carolina Macular Dystrophy Maps to Chromosome 5
Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2178 - 2183.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Michaelides, S. Johnson, A. Poulson, K. Bradshaw, C. Bellmann, D. M. Hunt, and A. T. Moore
An Autosomal Dominant Bull's-Eye Macular Dystrophy (MCDR2) that Maps to the Short Arm of Chromosome 4
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1657 - 1662.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. van der Spuy, J. P. Chapple, B. J. Clark, P. J. Luthert, C. S. Sethi, and M. E. Cheetham
The Leber congenital amaurosis gene product AIPL1 is localized exclusively in rod photoreceptors of the adult human retina
Hum. Mol. Genet., April 1, 2002; 11(7): 823 - 831.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. B. Bateman, D. D. Geyer, P. Flodman, M. Johannes, J. Sikela, N. Walter, A. T. Moreira, K. Clancy, and M. A. Spence
A New {beta}A1-Crystallin Splice Junction Mutation in Autosomal Dominant Cataract
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3278 - 3285.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
M. Weigel-lWeber, S. Fokstuen, B. Torok, G. Niemeyer, A. Schinzel, and M. Hergersberg
Codons 837 and 838 in the Retinal Guanylate Cyclase Gene on Chromosome 17p: Hot Spots for Mutations in Autosomal Dominant Cone-Rod Dystrophy?
Arch Ophthalmol, February 1, 2000; 118(2): 300 - 300.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Leicher, R. Bahring, D. Isbrandt, and O. Pongs
Coexpression of the KCNA3B Gene Product with Kv1.5 Leads to a Novel A-type Potassium Channel
J. Biol. Chem., December 25, 1998; 273(52): 35095 - 35101.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kelsell, R. E.
Right arrow Articles by Hunt, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelsell, R. E.
Right arrow Articles by Hunt, D. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?